Vienna Insurance Group Valuation

Is WSV2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of WSV2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: WSV2 (€30) is trading below our estimate of fair value (€97.02)

Significantly Below Fair Value: WSV2 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for WSV2?

Key metric: As WSV2 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for WSV2. This is calculated by dividing WSV2's market cap by their current earnings.
What is WSV2's PE Ratio?
PE Ratio7x
Earnings€559.63m
Market Cap€3.89b

Price to Earnings Ratio vs Peers

How does WSV2's PE Ratio compare to its peers?

The above table shows the PE ratio for WSV2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average12.1x
TLX Talanx
11.2x5.7%€21.2b
NBG6 NÜRNBERGER Beteiligungs-AG
13.5x38.8%€562.2m
RLV RheinLand Holding
11.8xn/a€111.4m
ALV Allianz
12.1x6.4%€114.9b
WSV2 Vienna Insurance Group
7x8.6%€3.9b

Price-To-Earnings vs Peers: WSV2 is good value based on its Price-To-Earnings Ratio (7x) compared to the peer average (12.2x).


Price to Earnings Ratio vs Industry

How does WSV2's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
WSV2 7.0xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: WSV2 is good value based on its Price-To-Earnings Ratio (7x) compared to the European Insurance industry average (12.1x).


Price to Earnings Ratio vs Fair Ratio

What is WSV2's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

WSV2 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7x
Fair PE Ratio11.3x

Price-To-Earnings vs Fair Ratio: WSV2 is good value based on its Price-To-Earnings Ratio (7x) compared to the estimated Fair Price-To-Earnings Ratio (11.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst WSV2 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€30.00
€35.00
+16.7%
17.4%€39.00€24.50n/a4
Dec ’25€29.25
€34.75
+18.8%
17.1%€39.00€24.50n/a4
Nov ’25€29.25
€34.50
+17.9%
16.9%€39.00€24.50n/a4
Oct ’25€29.50
€34.50
+16.9%
16.9%€39.00€24.50n/a4
Sep ’25€30.55
€34.58
+13.2%
17.0%€39.00€24.50n/a4
Aug ’25€29.65
€32.83
+10.7%
18.6%€39.00€24.50n/a3
Jul ’25€30.45
€32.50
+6.7%
18.5%€39.00€24.50n/a3
Jun ’25€29.50
€29.00
-1.7%
13.4%€34.00€24.50n/a3
May ’25€29.35
€29.00
-1.2%
13.4%€34.00€24.50n/a3
Apr ’25€28.95
€29.00
+0.2%
13.4%€34.00€24.50n/a3
Mar ’25€27.15
€29.75
+9.6%
4.2%€31.00€28.50n/a2
Feb ’25€26.50
€29.75
+12.3%
4.2%€31.00€28.50n/a2
Jan ’25€26.15
€29.75
+13.8%
4.2%€31.00€28.50n/a2
Nov ’24€25.20
€27.17
+7.8%
6.9%€28.50€24.50€29.253
Oct ’24€25.30
€27.17
+7.4%
6.9%€28.50€24.50€29.503
Sep ’24€24.75
€27.17
+9.8%
6.9%€28.50€24.50€30.553
Aug ’24€24.40
€27.17
+11.3%
6.9%€28.50€24.50€29.653
Jul ’24€23.90
€27.17
+13.7%
6.9%€28.50€24.50€30.453
Jun ’24€24.20
€27.17
+12.3%
6.9%€28.50€24.50€29.503
May ’24€26.70
€27.17
+1.7%
6.9%€28.50€24.50€29.353
Apr ’24€24.60
€27.17
+10.4%
6.9%€28.50€24.50€28.953
Mar ’24€26.70
€27.17
+1.7%
6.9%€28.50€24.50€27.153
Feb ’24€25.05
€27.17
+8.4%
6.9%€28.50€24.50€26.503
Jan ’24€22.20
€26.80
+20.7%
6.3%€28.50€24.50€26.153
Dec ’23€22.50
€26.80
+19.1%
6.3%€28.50€24.50€26.153

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 11:51
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vienna Insurance Group AG is covered by 30 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel BischofBaader Helvea Equity Research
Andrew BroadfieldBarclays
Claudia GaspariBarclays